GlaxoSmithKline (GSK) has agreed to confidential settlements in about 200 lawsuits by families who alleged the mothers’ use of the antidepressant Paxil (paroxetine) during pregnancy caused birth defects in their children (In re Paxil Pregnancy Cases).
The suits were part of consolidated proceedings in the Court of Common Pleas for Philadelphia County. Following settlement, they were dismissed from the docket by Judge Sandra Mazer Moss.
Momentum toward settlement began after an October 2009 trial, in which a jury awarded $2.5 million in compensatory damages on behalf of Lyam Kilker, according to Jamie Sheller, an attorney for Kilker and ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.